SCHEMBL7965360

SCHEMBL7965360

CCCOc1cc(C)ccc1C(=N)OCC.F[B-](F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.38
ALDH1A1 P00352 5/20 0.38
POLB P06746 2/20 0.38
GPR55 Q9Y2T6 1/20 0.38
L3MBTL1 Q9Y468 7/20 0.37
RAB9A P51151 2/20 0.37
ATM Q13315 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 3/20 0.35
SMN1; SMN2 Q16637 5/20 0.34
HPGD P15428 3/20 0.34
DGAT1 O75907 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7961052 0.86 MTNR1A (0.39) MAPTALDH1A1POLBL3MBTL1RAB9A
SCHEMBL11628940 0.82 LMNA (0.42) MAPTALDH1A1L3MBTL1TSHRSMN1; SMN2
Hydrochloric Acid SCHEMBL4697925 0.80 MTNR1A (0.41) MAPTALDH1A1POLBL3MBTL1CYP1A2
SCHEMBL7962857 0.80 MTNR1A (0.41) MAPTALDH1A1POLBL3MBTL1ATM
SCHEMBL7963098 0.79 HTR2C (0.40) MAPTALDH1A1POLBL3MBTL1RAB9A
SCHEMBL11630789 0.78 LMNA (0.48) MAPTALDH1A1L3MBTL1CYP1A2TSHR
SCHEMBL7950395 0.78 PTGER1 (0.42) MAPTALDH1A1L3MBTL1RAB9ATSHR
SCHEMBL14974921 0.78 CYP1A2 (0.53) MAPTALDH1A1L3MBTL1RAB9ACYP1A2
Hydrochloric Acid SCHEMBL7960837 0.78 MAPT (0.43) MAPTALDH1A1POLBGPR55RAB9A
SCHEMBL23267707 0.74 SMN1; SMN2 (0.56) MAPTALDH1A1POLBGPR55L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6200980-B1 ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS CELL PATHWAYS, INC. 2001-03-13 US disclosed
EP-0352960-B1 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE FRENCH LAB (GB) 1994-10-26 EP disclosed
US-5073559-A 2-Substituted purinone having phosphodiesterase inhibitory activity SMITH KLINE & FRENCH LABORATORIES, LTD. (GB) 1991-12-17 US disclosed
EP-0352960-A2 Purine compounds, process for their preparation and pharmaceutical compositions SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1990-01-31 EP disclosed